Thompson Elizabeth H.Z. — SEC Form 4 filings
SEC reporting owner CIK 1861477. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-31.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-14 to 2026-07-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 19,993 shares, $506,412 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 16,508 shares @ $26.13 ($431,354) in ACADIA PHARMACEUTICALS INC, filed 2026-07-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | EVP, Head of Research & Dev | 5 | — | 3 legs · 19,993 sh · $506,412 | 10 |
| IGM Biosciences, Inc. (IGMS) | Director | 8 | — | — | 8 |
Form 4 filings — Thompson Elizabeth H.Z.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-31 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 32,272 · Sale (S): 16,508 @ $26.13 · Sale (S): 50 @ $26.17 · Option exercise (M): 32,272 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 6,715 · Sale (S): 3,435 @ $21.47 · Option exercise (M): 6,715 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 101,574 (derivative) @ $0 · Grant/award (A): 29,548 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | IGM Biosciences, Inc. (IGMS) | Disposition to issuer (D): 7,196 | EDGAR |
| 2025-07-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 694 @ $0 | EDGAR |
| 2025-04-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 694 @ $0 | EDGAR |
| 2025-03-26 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 91,395 (derivative) @ $0 · Grant/award (A): 26,861 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 1,452 @ $0 | EDGAR |
| 2024-10-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 1,452 @ $0 | EDGAR |
| 2024-08-13 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 324,582 (derivative) @ $0 · Grant/award (A): 64,544 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 1,452 @ $0 | EDGAR |
| 2024-04-02 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 1,452 @ $0 | EDGAR |
| 2024-03-14 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 29,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →